highly significantP = 0.001
The results showed a highly significant reduction (34%, P = 0.001) in UTI recurrences in the active treatment group compared with placebo.
The results showed a highly significant reduction (34%, P = 0.001) in UTI recurrences in the active treatment group compared with placebo.